 FT MYERS, FL ACCESSWIRE May 27, 2021 NeoGenomics, Inc. NASDAQ:NEO, a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that senior management will be participating virtually in multiple upcoming institutional investor conferences. Management will participate in investor meetings at the 18th Annual Craig-Hallum Institutional Investor Conference on Wednesday, June 2nd. 